Array Biopharma Inc
ARRY
ARRY was delisted on the 29th of July, 2019.
122 hedge funds and large institutions have $587M invested in Array Biopharma Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 9 closing their positions.
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
36% more capital invested
Capital invested by funds: $432M → $587M (+$155M)
12% more call options, than puts
Call options by funds: $4.84M | Put options by funds: $4.32M
9% more funds holding
Funds holding: 112 → 122 (+10)
9% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 35
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$13.9M |
| 2 |
First Manhattan
New York
|
+$5.14M |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$3.96M |
| 4 |
Axa
Paris,
France
|
+$3.38M |
| 5 |
O
OrbiMed
New York
|
+$3.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$8.32M |
| 2 |
QF
QVT Financial
New York
|
-$8.03M |
| 3 |
State Street
Boston,
Massachusetts
|
-$5.9M |
| 4 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$5.56M |
| 5 |
AC
Apex Capital
Orinda,
California
|
-$4.34M |
ARRY Hedge Fund Activity: Q4 2014 in Review
122 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2014, worth a combined $587M — up 36% from $432M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ARRY positions and 9 closed out — a net gain of 12 holders — while 38 added to existing stakes and 35 trimmed.
The largest buyer was Redmile Group, adding an estimated $13.9M. The largest seller was BVF Inc, cutting an estimated $8.32M.
- 122 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2014, up from 112 in Q3 2014.
- Funds reported $587M of Array Biopharma Inc stock for Q4 2014, up 36% quarter-over-quarter.
- 21 funds opened new Array Biopharma Inc positions in Q4 2014 and 9 closed out, a net change of +12 holders.
- The largest Array Biopharma Inc buyer in Q4 2014 was Redmile Group, an estimated $13.9M added.
- The largest Array Biopharma Inc seller in Q4 2014 was BVF Inc, an estimated $8.32M sold.
Based on aggregated 13F filings for Q4 2014.